Cardiff Oncology, Inc. (DE:XE7C)
FRANKFURT:XE7C

Cardiff Oncology (XE7C) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Buy
9Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
2Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Cardiff Oncology, Inc.’s (XE7C) Moving Averages Convergence Divergence (MACD) indicator is -0.19, suggesting Cardiff Oncology, Inc. is a Sell.
Cardiff Oncology, Inc.’s (XE7C) 20-Day exponential moving average is 2.17, while Cardiff Oncology, Inc.’s (XE7C) share price is €2.23, making it a Buy.
Cardiff Oncology, Inc.’s (XE7C) 50-Day exponential moving average is 2.57, while Cardiff Oncology, Inc.’s (XE7C) share price is €2.23, making it a Sell.

Cardiff Oncology (XE7C) Pivot Points

Jul 26, 2024, 10:20 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.94
1.95
1.97
1.97
1.99
1.99
2.01
Fibonacci
1.95
1.96
1.96
1.97
1.98
1.99
1.99
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cardiff Oncology (XE7C) Moving Averages

Jul 26, 2024, 10:20 PM
Period
Simple
Exponential
MA5
2.02Buy
2.06Buy
MA10
2.01Buy
2.06Buy
MA20
2.11Buy
2.17Buy
MA50
2.62Sell
2.57Sell
MA100
3.28Sell
2.72Sell
MA200
2.25Sell
2.23Buy
Cardiff Oncology, Inc.’s (XE7C) 10-Day exponential moving average is 2.06, while Cardiff Oncology, Inc.’s (XE7C) share price is €2.23, making it a Buy.
Cardiff Oncology, Inc.’s (XE7C) 100-Day exponential moving average is 2.72, while Cardiff Oncology, Inc.’s (XE7C) share price is €2.23, making it a Sell.
Cardiff Oncology, Inc.’s (XE7C) stock price is €2.23 and Cardiff Oncology, Inc.’s (XE7C) 50-day simple moving average is 2.62, creating a Sell signal.
Cardiff Oncology, Inc.’s (XE7C) stock price is €2.23 and Cardiff Oncology, Inc.’s (XE7C) 100-day simple moving average is 3.28, creating a Sell signal.
Cardiff Oncology, Inc.’s (XE7C) stock price is €2.23 and Cardiff Oncology, Inc.’s (XE7C) 200-day simple moving average is 2.25, creating a Sell signal.

Cardiff Oncology (XE7C) Technical Indicators

Jul 26, 2024, 10:20 PM
Name
Value
Implied Action
RSI (14)
48.15
Neutral
STOCH (9,6)
62.31
Neutral
STOCHRSI (14)
55.47
Neutral
MACD (12,26)
-0.19
Sell
ADX (14)
41.10
Neutral
Williams %R
0.00
-
CCI (14)
63.04
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
56.72
Neutral
ROC
0.90
Buy
Cardiff Oncology, Inc.’s (XE7C) Relative Strength Index (RSI) is 48.15, creating a Neutral signal.
Cardiff Oncology, Inc.’s (XE7C) Trend Strength Indicator (ADX) is 41.10, creating a Neutral signal.
Cardiff Oncology, Inc.’s (XE7C) Commodity Channel Index (CCI) is 63.04, creating a Neutral signal.
Cardiff Oncology, Inc.’s (XE7C) Price Rate of Change (ROC) is 0.90, creating a Buy signal.

FAQ

Is XE7C a Buy, Hold, or Sell?
Based on XE7C’s technical indicators, XE7C is a Buy.
    What is XE7C’s RSI (14)?
    XE7C’s RSI (14) is 48.15, which suggests XE7C is a Neutral.
      What is XE7C’s MACD?
      XE7C’s MACD is -0.19, which suggests XE7C is a Sell.
        What is XE7C’s 5-day moving average?
        XE7C’s 5-day moving average is 2.02, which suggests XE7C is a Buy.
          What is XE7C’s 20-day moving average?
          XE7C 20-day moving average is 2.11, which suggests XE7C is a Buy.
            What is XE7C’s 50-day moving average?
            XE7C’s 50-day moving average is 2.62, which suggests XE7C is a Sell.
              What is XE7C’s 200-day moving average?
              XE7C’s 200-day moving average is 2.25, which suggests XE7C is a Sell.
                What is XE7C’s Williams % R (14)?
                Currently, no data Available
                What is XE7C’s CCI (14)?
                XE7C’s CCI (14) is 63.04, which suggests XE7C is a Neutral.
                  What is the share price of Cardiff Oncology, Inc.?
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis